127 related articles for article (PubMed ID: 8866142)
1. Comparison of two methods to detect P-glycoprotein in patients with chronic lymphocytic leukaemia.
Chin-Yee I; Alshammari S; Anderson L; Kadri M; Keeney M
Clin Lab Haematol; 1996 Jun; 18(2):99-104. PubMed ID: 8866142
[TBL] [Abstract][Full Text] [Related]
2. Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphocytic leukaemia and correlation with in vitro drug resistance.
Sparrow RL; Hall FJ; Siregar H; Van der Weyden MB
Leuk Res; 1993 Nov; 17(11):941-7. PubMed ID: 7901453
[TBL] [Abstract][Full Text] [Related]
3. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.
Broxterman HJ; Sonneveld P; Feller N; Ossenkoppele GJ; Währer DC; Eekman CA; Schoester M; Lankelma J; Pinedo HM; Löwenberg B; Schuurhuis GJ
Blood; 1996 Jun; 87(11):4809-16. PubMed ID: 8639853
[TBL] [Abstract][Full Text] [Related]
4. Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?
Broxterman HJ; Sonneveld P; Pieters R; Lankelma J; Eekman CA; Loonen AH; Schoester M; Ossenkoppele GJ; Löwenberg B; Pinedo HM; Schuurhuis GJ
Leukemia; 1999 Feb; 13(2):258-65. PubMed ID: 10025900
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein inhibitors modulate accumulation and efflux of xenobiotics in extra and intracellular Toxoplasma gondii.
Sauvage V; Aubert D; Bonhomme A; Pinon JM; Millot JM
Mol Biochem Parasitol; 2004 Mar; 134(1):89-95. PubMed ID: 14747146
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells.
Michieli M; Damiani D; Ermacora A; Raspadori D; Michelutti A; Grimaz S; Fanin R; Russo D; Lauria F; Masolini P; Baccarani M
Br J Haematol; 1997 Feb; 96(2):356-65. PubMed ID: 9029025
[TBL] [Abstract][Full Text] [Related]
7. Comparison between anthracyclines and rhodamine-123 accumulation in chronic lymphoid leukemia: effect of cyclosporin A and verapamil.
Maia RC; Vasconcelos FC; Harab RC; Coelho AM; Dobbin JA; Rumjanek VM
Tumour Biol; 1998; 19(1):41-51. PubMed ID: 9422081
[TBL] [Abstract][Full Text] [Related]
8. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
Pallis M; Turzanski J; Langabeer S; Russell NH
Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783
[TBL] [Abstract][Full Text] [Related]
9. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
[TBL] [Abstract][Full Text] [Related]
10. Validation of a single point flow cytometric assay for determining P-glycoprotein activity in multidrug resistant cell lines.
Chin-Yee I; Crowther MA; Keeney M; Wright L; Daly S
Clin Lab Haematol; 1994 Sep; 16(3):261-72. PubMed ID: 7828413
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, fluo-3.
Wall DM; Sparrow R; Hu XF; Nadalin G; Zalcberg JR; Marschner IC; Van der Weyden M; Parkin JD
Eur J Cancer; 1993; 29A(7):1024-7. PubMed ID: 8098947
[TBL] [Abstract][Full Text] [Related]
12. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia.
Grey MR; Burgess R; Fisher A; Yin JA
Leuk Res; 1999 Jan; 23(1):29-35. PubMed ID: 9933132
[TBL] [Abstract][Full Text] [Related]
13. Liposome-encapsulated daunorubicin for PGP-related multidrug resistance.
Michieli M; Damiani D; Ermacora A; Masolini P; Michelutti A; Michelutti T; Russo D; Pea F; Baccarani M
Br J Haematol; 1999 Jul; 106(1):92-9. PubMed ID: 10444168
[TBL] [Abstract][Full Text] [Related]
14. In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.
Baines P; Limaye M; Hoy T; Padua RA; Whittaker J; al-Sabah A; Burnett A
Leuk Res; 1994 Sep; 18(9):683-91. PubMed ID: 7934144
[TBL] [Abstract][Full Text] [Related]
15. Detection of P-glycoprotein in cell lines and leukemic blasts: failure of select monoclonal antibodies to detect clinically significant Pgp levels in primary cells.
Taylor BJ; Olson DP; Ivy SP
Leuk Res; 2001 Dec; 25(12):1127-35. PubMed ID: 11684287
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurement of cellular P-glycoprotein content and function by multiparametric flow-cytometry.
Müller MR; Lennartz K; Baack B; Heim MM; Seeber S; Scheulen ME
Int J Clin Pharmacol Ther; 2000 Apr; 38(4):180-6. PubMed ID: 10783827
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia.
Michieli M; Damiani D; Ermacora A; Geromin A; Michelutti A; Masolini P; Baccarani M
Br J Haematol; 2000 Mar; 108(4):703-9. PubMed ID: 10792272
[TBL] [Abstract][Full Text] [Related]
18. Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia.
Poulain S; Lepelley P; Cambier N; Cosson A; Fenaux P; Wattel E
Adv Exp Med Biol; 1999; 457():57-63. PubMed ID: 10500780
[TBL] [Abstract][Full Text] [Related]
19. Activation of human peripheral blood T cells does not lead to increased P-glycoprotein expression.
Mu XY; Gosland MP; Bartik MM; Schimmelpfennig J; Kay NE
J Clin Immunol; 1999 Jul; 19(4):239-46. PubMed ID: 10471978
[TBL] [Abstract][Full Text] [Related]
20. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
Grey M; Borg AG; Wood P; Burgess R; Fisher A; Yin JA
Leuk Res; 1997 Sep; 21(9):867-74. PubMed ID: 9393602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
